Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.840 | 1.330 | -0.5100 |
| Révision: | $1.12B | $999.80M | $45.00M |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.940 | 1.940 | 0.0000 |
| Révision: | $958.13M | $849.70M | $33.37M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.590 | 1.510 | -0.0800 |
| Révision: | $1.01B | $903.40M | $48.00M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.140 | 0.990 | -0.1500 |
| Révision: | $1.03B | $930.70M | $55.00M |
